Malte Peters, departing MorphoSys chief R&D officer (UKBIO19)
MorphoSys woos Merck KGaA vet to lead late-stage push for blockbuster prospect
MorphoSys made it clear when it shuttered all US-based discovery work earlier this year that it wants to keep its research focus in its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
